Last reviewed · How we verify
NCT04103788
Evaluation of Increased Absorption of a Curcumin Emulsion (CurQ+) in Healthy Volunteers
NA trial testing 95% Curcuminoid Powder in Bioavailability in 10 participants. Completed in 13 December 2018.
14 April 2018
Quick facts
| Lead sponsor | ESM Technologies, LLC |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 10 |
| Start date | 27 March 2018 |
| Primary completion | 14 April 2018 |
| Estimated completion | 13 December 2018 |
| Sites | 1 location across United States |
Drugs / interventions tested
- 95% Curcuminoid Powder
- CurQ+
Conditions studied
- Bioavailability — all drugs for Bioavailability →
Sponsor
ESM Technologies, LLC
Who can join
Adults 21 to 75, any sex, with Bioavailability. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is intended to evaluate the comparative effects of direct analysis of serum samples versus pre-treatment with enzymatic hydrolysis in split samples obtained from dosing with a highly absorbed curcumin emulsion product that is commercially available as BIOCURC.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Reconnoitering the Therapeutic Role of Curcumin in Disease Prevention and Treatment: Lessons Learnt and Future Directions.
Sivani BM, Azzeh M, Patnaik R, Pantea Stoian A, et al · · 2022 · cited 26× · PMID 35888763 · DOI 10.3390/metabo12070639 -
The fallacy of enzymatic hydrolysis for the determination of bioactive curcumin in plasma samples as an indication of bioavailability: a comparative study.
Stohs SJ, Chen CYO, Preuss HG, Ray SD, et al · · 2019 · cited 17× · PMID 31684927 · DOI 10.1186/s12906-019-2699-x
Verify or expand the search:
- PubMed search for NCT04103788
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Bioavailability
Currently open trials in the same condition.
- NCT07063173 — Bioavailability of Ration Items Containing Tart Cherry Extract · NA · recruiting
- NCT05774704 — Curcumin and Retinal Study · Phase 1, PHASE2 · recruiting
Other ESM Technologies, LLC trials
Trials by the same sponsor.
- NCT07188051 — Ovolux Beauty From Within Trial#2 · NA · enrolling by invitation
- NCT06177483 — Bioavailability Evaluation of CurQ+ Curcumin Formulation · NA · completed
- NCT06148337 — Eggshell Membrane Beauty From Within Trial · NA · completed
- NCT03769857 — NEM® + BIOCURC® Versus Placebo in Exercised-induced Joint Pain, Stiffness, & Cartilage Turnover in Healthy Men & Women · NA · completed
- NCT03679923 — NEM® Versus Placebo in Exercised-induced Joint Pain, Stiffness, & Cartilage Turnover in Healthy Men & Women · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04103788 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by ESM Technologies, LLC
- Last refreshed: 13 December 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04103788.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing